Skip to content
Fear and GreedStocks25Crypto21
Start for free
To the full analysis

Clover Health Investments stock: valuation and P/E

CLOV
$4.88Closing price of 12 Nov 2026MEQIRI Score 51 out of 100

Clover Health Investments trades at a P/E of 218.5 (Medical (Healthcare Plans) median 22.9).

Daily figure as of 13 Nov 2026

P/E
218.5
P/S
0.9
P/B
6.96
PEG
7.51

Against its own valuation history

Each fiscal year is shown with its P/E on the year-end date, using the price at the time.

There is no reliable data on this for this company.

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Original filings at the SECReport a data error

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral since 7 Nov 2026, previously Weak
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
Full disclosures, methodology and data sourcesAll ratings of the last 12 monthsHow the score is calculated

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy